SCHEMBL29139810

SCHEMBL29139810

Nc1ncc2ncn(-c3ccccc3)c2n1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 6/20 0.47
▸ EGFR P00533 1/20 0.47
▸ PI4KA P42356 1/20 0.47
▸ PI4K2B Q8TCG2 1/20 0.47
▸ PI4K2A Q9BTU6 1/20 0.47
▸ PI4KB Q9UBF8 1/20 0.47
▸ HTT P42858 2/20 0.47
▸ ADORA2A P29274 1/20 0.47
▸ XDH P47989 1/20 0.46
▸ PDE10A Q9Y233 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ ROCK1 Q13464 1/20 0.42
▸ DHFR P00374 1/20 0.42
▸ SRC P12931 1/20 0.41
▸ HCAR1 Q9BXC0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenol SCHEMBL28142595 0.93 FGFR1 (0.49) FGFR1EGFRPI4KAPI4K2BPI4K2A
Quinoline SCHEMBL27973568 0.89 ALDH1A1 (0.45) FGFR1EGFRPI4KAPI4K2BPI4K2A
SCHEMBL4978113 0.84 XDH (0.48) FGFR1HTTXDHKDM4EALDH1A1
SCHEMBL30219641 0.82 DHFR (0.49) EGFRPI4KAPI4K2BPI4K2API4KB
SCHEMBL28301793 0.82 DHFR (0.49) EGFRPI4KAPI4K2BPI4K2API4KB
SCHEMBL11916214 0.80 FGFR1 (0.47) FGFR1EGFRPI4KAPI4K2BPI4K2A
SCHEMBL28198782 0.80 FGFR1 (0.47) FGFR1HTTPDE10AALDH1A1SRC
SCHEMBL17802582 0.79 CFTR (0.54) FGFR1KDM4EALDH1A1SMN1; SMN2ROCK1
SCHEMBL27745688 0.78 PI4KA (0.52) PI4KAPI4K2BPI4K2API4KBHTT
SCHEMBL30069229 0.76 FGFR1 (0.45) FGFR1HTTPDE10AALDH1A1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114127063-B Pyrimidine five-membered heterocyclic compounds and application thereof as mutant IDH2 inhibitor 上海仕谱生物科技有限公司 2023-12-01 — — CN disclosed
Send feedback